Natural Killer Cell therapies in Immunotherapy market worth $254B revolutionized by CAR-NK cells, engineered to evade immune system, enhance cancer destruction.

Unusual Whales
2025.10.17 13:51
A news commentary by Equity Insider reported on behalf of GT Biopharma, Inc. stated that MIT and Harvard researchers have developed specialized CAR-NK cells that are designed to evade detection by the immune system and demonstrate enhanced efficacy in combating cancer. This breakthrough was achieved on October 17, 2025, in Vancouver, BC. The engineered CAR-NK cells show promise in significantly improving cancer treatment due to their ability to effectively target and destroy cancer cells.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.